The Recall Desk

Manufacturer

Vilvet Pharmaceuticals Inc.

2 recalls in our database name Vilvet Pharmaceuticals Inc. as the manufacturing or recalling firm.

What the numbers show

Total
2
Critical
0
Severe
0
Most recent
2020-08-12

Of the 2 recalls from Vilvet Pharmaceuticals Inc. we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 0 (0%) are Severe.

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

1–2 of 2

  • ModerateFDA (Drugs)·D-1487-2020·2020-08-12

    Vilvet Pharmaceuticals Recalls VILAMIT MB Due to cGMP Deviations

    Vilvet Pharmaceuticals is recalling 11,640 bottles of VILAMIT MB capsules due to current Good Manufacturing Practice (cGMP) deviations. The recall is voluntary and nationwide.

    Product
    VILAMIT MB (118 mg methenamine, 36 mg phenyl salicylate, 40.8 mg sodium phosphate monobasic, 10.0 mg methylene blue and 0.12 mg hyoscyamine sulfate), Rx Only, 100 Capsules per Bottle, Manufactured for: Vilvet Pharmaceuticals Inc., Chester Springs, PA 18425, NDC 71186-002-35.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1488-2020·2020-08-12

    Vilvet Pharmaceuticals Recalls VILEVEV MB Urinary Antiseptic Due to cGMP Deviations

    Vilvet Pharmaceuticals is voluntarily recalling 1,716 bottles of VILEVEV MB Urinary Antiseptic due to current Good Manufacturing Practice (cGMP) deviations.

    Product
    VILEVEV MB Urinary Antispetic (81.0 mg methenamine, 40.8 mg sodium phosphate monobasic and 10.8 mg methylene blue, 0.12 mg hyoscyamine sulfate and 32.4 mg phenyl salicylate), Rx Only, 90 Tablets per Bottle, Manufactured for: Vilvet Pharmaceuticals, Inc., Chester Springs, PA…
    Category
    Drug
    Distribution
    Distributed nationwide